TraceLink's Continued Momentum Fuels Strong Company Growth and Investments in Q4 2019

TraceLink's Continued Momentum Fuels Strong Company Growth and Investments in Q4 2019

PR Newswire

NORTH READING, Massachusetts, March 10, 2020

Grows leadership team with additional industry experts, significantly invests in research and development, and increases global footprint with new office openings and expansion

NORTH READING, Massachusetts, March 10, 2020 /PRNewswire/ -- TraceLink Inc., a network-based platform company with the world's largest integrated digital supply network, today announced financial and company results for the fourth quarter of 2019.

Growth highlights for 2019 include:

"The last quarter of 2019 represented considerable growth for TraceLink and puts the Company in a very exciting position for 2020. The combination of our rapid network expansion with our new Digital Network Platform has inspired our customers to realize how their serialization investments can be leveraged to combat industry-wide challenges such as drug shortages and recalls," said Shabbir Dahod, president and CEO, TraceLink. "The momentum will continue this year, as we bring new products to market that will help companies digitally optimize their supply chains and benefit from serialized inventory with a digital supply network. We remain committed to making the necessary investments for long term success to support our mission of creating a healthier, safer world."

Additional Q4 Company highlights and milestones include:

Follow TraceLink:

About TraceLink
TraceLink is a network-based platform company that leverages its digital supply network and digital network platform to bend the supply chain around the patient. Through its industry-leading digital supply network, the TraceLink Digital Network Platform can enable seamless data sharing and process orchestration across the entire healthcare industry, enabling the creation of a real-time, patient-driven supply network. Leading life science companies, hospitals and retail pharmacies trust TraceLink to deliver complete global connectivity, visibility and traceability of pharmaceuticals, ensuring that every patient gets the medicines they need, when they need them, safely and securely. For more information on TraceLink and our solutions, visit

TraceLink is funded by Georgian Partners, Willett Advisors LLC, Vulcan Capital, Goldman Sachs, FirstMark CapitalVolition Capital and F-Prime Capital.

Logo -

Voltar noticias em Inglês